What’s Hot Today: American Airlines Group Inc. (NASDAQ:AAL), Enbridge Energy Partners, L.P. (NYSE:EEP), Valeant Pharmaceuticals (NYSE:VRX), UBIC, Inc. (NASDAQ:UBIC), Atlatsa Resources (NYSEMKT:ATL)

American Airlines Group Inc. (NASDAQ:AAL) shares increased 3.88% in last trading session and ended the day at $41.21. AAL Gross Margin is 31.30% and its return on assets is 7.40%. American Airlines Group Inc. (NASDAQ:AAL) quarterly performance is -13.48%. The merger creating the world’s largest airline is expected to complete a key step Oct. 17, when all flight reservations for US Airways are transferred to the computer systems for American Airlines Group Inc. (NASDAQ:AAL). The airlines announced Friday that, over a three-month period starting July 17, all reservations made for US Airways flights will be gradually transferred to the American Airlines system. The conversion is due to be completed by Oct. 17.

On 10 July, Enbridge Energy Partners, L.P. (NYSE:EEP) shares increased 0.77% and was closed at $33.86. EEP EPS growth in last 5 year was -13.60%. Enbridge Energy Partners, L.P. (NYSE:EEP) year to date (YTD) performance is -12.63%. Enbridge Energy Partners, L.P. (NYSE: EEP) (“Enbridge Partners”) will host a webcast conference call to discuss its 2015 second quarter financial results, on Thursday, July 30, 2015, at Enbridge Energy Partners L.P. Earnings Call.

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) belongs to Healthcare sector. Its net profit margin is 11.80% and weekly performance is 1.68%. On last trading day company shares ended up $232.32. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) distance from 50-day simple moving average (SMA50) is 1.66%. Eyegate Pharmaceuticals, Inc. (OTCQB:EYEG) announced that it has entered into an exclusive, worldwide licensing agreement with a subsidiary of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) through which EyeGate has granted Valeant exclusive, worldwide commercial and manufacturing rights to its EyeGate® II Delivery System and EGP-437 combination product (“Product”) in the field of uveitis, as well as a right of last negotiation to license the Product for other indications.

UBIC, Inc. (NASDAQ:UBIC) shares fell -9.60% in last trading session and ended the day at $13.08. UBIC, Inc. (NASDAQ:UBIC) quarterly performance is -18.30%. UBIC, Inc. (NASDAQ:UBIC) announced that it has established a review center in Washington, D.C., in order to meet demand for large-scale review projects in the U.S. market. In order to expand its business in the United States, the primary market for eDiscovery support services, and to enhance its U.S. business operations, UBIC acquired TechLaw Solutions, Inc. and made it a subsidiary in August 2014.

On 10 July, Atlatsa Resources Corporation (NYSEMKT:ATL) shares fell -23.27% and was closed at $0.06. ATL EPS growth in last 5 year was 15.00%. Atlatsa Resources Corporation (NYSEMKT:ATL) year to date (YTD) performance is -67.20%. Atlatsa Resources Corporation (NYSEMKT:ATL) announced its intention to file a Form 25 (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934) with the U.S. Securities and Exchange Commission (the “SEC”) to voluntarily withdraw its common shares from listing on the NYSE MKT.

Leave a Reply

Your email address will not be published. Required fields are marked *